⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

BlueRock Therapeutics

Name: BlueRock Therapeutics - AI Visibility Score
Creator: Engagemii
Published: 2026-06-27T20:57:49.753Z
License: https://creativecommons.org/licenses/by/4.0/

Unclaimed

AEO Score: 5/10

Monitoring for AI engine activity

In the Engagemii AEO index

expditestudy.com

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. BlueRock Therapeutics just got measured.

5/10 means BlueRock Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About BlueRock Therapeutics

No Time to Waste exPDite-2 is a double-blind, simulated surgery-controlled phase 3 study evaluating the potential efficacy and safety of an investigational cell therapy called bemdaneprocel (bem-da-nepro-cell). Find out if you or someone you know is right for exPDite-2 OR Call us at +1-877-380-3967 to see if you may participate Bemdaneprocel

Key Topics

No Time to Waste

How is bemdaneprocel thought to work?

Exploring a new way: Creating bemdaneprocel

Creating a cell therapy

Are you a good fit for exPDite-2?

For qualified study participants, all treatments and tests may be provided at no charge. Support with travel associated with the study and reasonable reimbursement costs for you and your care partner may be provided throughout the exPDite-2 study. The study doctor and/or their staff will discuss this with you at your first visit.